VC firm blog
Everything we hold that OneVentures portfolio published.
The most recent 60 of 61 articles we hold from OneVentures portfolio.
Publisher post sharing its healthcare partner's profile in the business press, plus coverage of a biotech firm's $1.6b takeover, a vaccine company naming a new CEO, and a software firm being acquired.
Under OneVentures portfolio ·leads this story in the feed
A OneVentures post announcing the sale of digital health group Eucalyptus to an unnamed New York stock exchange-listed healthcare company for 1.6 billion dollars, set against pharmaceutical appetite for local biotech facing patent expiries.
A fund's insights listing: its headline flags Vaxxas naming an ex-Merck vaccines chief as CEO, while linked teasers report Eucalyptus' $1.6b sale and Accel-KKR's takeover of Phocas.
Also OneVentures portfolio·AFR Technology·phocassoftware.com
Curated OneVentures roundup: Eucalyptus sold to a New York-listed healthcare group for $1.6 billion and Vaxxas named ex-Merck vaccines president David Peacock as CEO, plus patent-cliff and women-in-tech links.
A OneVentures blog post flags an artificial heart developer it has backed as out soliciting fresh capital; the text provided names no company, investors, or completed round.
A OneVentures blog stub links to Capital Brief's report that the venture firm is approaching a major growth milestone, has added key staff, and is preparing a fresh fund.
OneVentures' insights feed highlights a pharma patent-cliff analysis, an AFR feature, Eucalyptus' $1.6b sale to a US healthcare group, and Vaxxas naming David Peacock chief executive.
The venture firm's own post says it is out raising for a new vehicle to fill space corporate investors have vacated; the text states no close and no committed amount.
OneVentures' media-roundup page archives press coverage of the firm and of Employment Hero's major funding round, while its headline funds-under-management milestone remains an intention rather than a completed close.
A OneVentures blog post linking to Sky News coverage of an Australian engineer's artificial heart invention, plus a related item on US regulatory clearance for BiVACOR's heart device human trial.
OneVentures insights listing linking to coverage of Eucalyptus's $1.6b sale to a US-listed healthcare company and Vaxxas hiring a former Merck vaccines president as CEO.
Publisher's post about a venture firm multiplying its money thirteen-fold on one startup bet; the page also carries linked reports of Eucalyptus's $1.6 billion sale and Vaxxas naming David Peacock chief executive.
US regulators cleared first-in-human testing of BiVACOR's total artificial heart; the OneVentures page also links earlier coverage and the Biomedical Translation Fund's investment in the device.
A OneVentures post announcing Employment Hero's $263 million raise, billed as the year's largest, linking out to the Financial Review for the full story.
Under OneVentures portfolio ·leads this story in the feed
OneVentures' insights page rounds up media coverage: an AFR report on Employment Hero's $263 million raise, a Forbes piece on OneVentures reaching $1 billion under management, and two AFR features on venture funding.
OneVentures links out to Vaxxas's announcement that the biotech has opened a manufacturing site for its needle-free vaccine patch.
OneVentures' blog links to an Australian Financial Review report saying biotech ImmVirX has secured a raise at a $75 million valuation; the post itself gives no amount, investors, or dates.
Also SmartCompany·Techboard
OneVentures' blog post pointing readers to Financial Review coverage of the firm and the artificial-heart developer BiVACOR; the post itself contains no deal details.
A OneVentures post reports a needle-free vaccine developer raising A$34 million; linked items on the page note Eucalyptus's $1.6 billion sale to a US-listed healthcare firm and Vaxxas naming David Peacock chief executive.
Also Blackbird Ventures portfolio·Startup Daily·SmartCompany·Dealroom·SmartCompany·Startup Daily·AFR Technology·Dealroom·Forbes Australia
Under Brandon BioCatalyst portfolio ·leads this story in the feed
OneVentures publishes an interview with Edrolo co-founder and co-CEO Ben Sze, discussing the education company. No funding, exit, hire or cohort details are stated in the available text.
OneVentures announces it led Kepler Analytics' AU$22 million Series A, describing the Melbourne retail analytics firm's sensor technology, customer base, growth and expansion plans.
Under Shearwater Capital portfolio ·leads this story in the feed
OneVentures announces it led Flippa's AU$15 million Series A. The post profiles the Melbourne-founded marketplace for buying and selling online businesses, its founders, its growth, and the trends behind the investment thesis.
Under OneVentures portfolio ·leads this story in the feed
Short news post announcing that Flippa, an online marketplace matching buyers and sellers of digital assets and businesses, has secured $11 million in funding; the full story sits behind a link to TechCrunch.
Under OneVentures portfolio ·leads this story in the feed
A OneVentures insights page linking to an AFR piece about selling companies online, with a related item reporting Flippa raising eleven million dollars to connect buyers and sellers of internet businesses.
Also OneVentures portfolio·OneVentures portfolio·TechCrunch Venture·TechCrunch Venture·Startup Daily
A short OneVentures blog post that simply points readers to a Bloomberg article arguing permanent artificial hearts are nearing reality, adding no details, companies, or funding of its own.
OneVentures provided debt financing to Hivery, marking the firm's tenth credit deal, in a brief post pointing readers to the Financial Review's fuller coverage.
OneVentures relays an InnovationAus report that Queensland's government has pledged A$20 million to a vaccine manufacturer the post never names.
A brief OneVentures post linking to newspaper coverage of a needle-free COVID-19 vaccination patch showing promise, with a related item about Vaxxas opening a manufacturing facility for its patch.
OneVentures announces disability-sector software firm Lumary has raised $17 million, with OneVentures and Salesforce investing, linking to fuller coverage by SmartCompany and the Australian Financial Review.
Under OneVentures portfolio ·leads this story in the feed
Under OneVentures portfolio ·leads this story in the feed
OneVentures' blog post announces a $17 million investment in Lumary alongside Salesforce, pointing readers to full coverage in the Australian Financial Review.
Also OneVentures portfolio·OneVentures portfolio·SmartCompany·Cut Through Venture·SmartCompany
A OneVentures blog stub that only links out to an AFR piece; its headline reports an unnamed HR tech company raising $45 million during a remote-working boom, with no article text on the page.
A OneVentures blog post linking to TechCrunch's report that Australian company Employment Hero has raised A$45 million to fund its expansion overseas.
Under OneVentures portfolio ·leads this story in the feed
A brief OneVentures blog post that simply links readers to a New Yorker feature on engineering an artificial heart; the post itself states no funding, deal, or company news.
OneVentures' site announces that HR software company Employment Hero has completed its funding round, linking out to the full Financial Review coverage.
Also OneVentures portfolio·TechCrunch Venture·SmartCompany·Cut Through Venture·SmartCompany·Startup Daily·TechCrunch Venture
OneVentures' investment note explains why it provided a venture credit facility to Coassemble, a SaaS microcourse platform, crediting EVP's Justin Lipman and Mark Velic with the introduction and praising cofounders Ryan and Jude.
Under OneVentures portfolio ·leads this story in the feed
OneVentures flags AFR coverage of Coassemble, a Newcastle software startup, raising $1.5 million, with no investors or further deal details given on this page.
OneVentures' note on InDebted covers a newly closed debt facility with internal equity funding its US acquisition and expansion, plus American executive hires ahead of a planned Series B.
OneVentures' insights page announces that data analytics company Phocas Software has raised 45 million dollars in venture funding after two decades of bootstrapping, linking to fuller coverage elsewhere.
Under OneVentures portfolio ·leads this story in the feed
OneVentures' blog announces data analytics firm Phocas has raised 45 million dollars in venture funding, pointing readers to full coverage in the Australian Financial Review and SmartCompany.
Under OneVentures portfolio ·leads this story in the feed
OneVentures has reached a first close on the initial instalment of its new venture fund, sized at $200 million, with further detail carried in Australian Financial Review coverage.
OneVentures points readers to Financial Review coverage of fresh funding raised by Queensland needle-free vaccine patch developer Vaxxas, without stating the amount or backers.
OneVentures points readers to an Australian Financial Review report that an unnamed e-bike startup has raised a $16 million round led by a clean energy fund.
A OneVentures blog pointer to Australian Business Review coverage of how logistics company Shippit cut costs and became profitable during COVID, with no funding, exit or people details stated.
Blade Therapeutics reports its Phase 2 trial of BLD-2660 in COVID-19 pneumonia has enrolled half its 120-patient goal, with full enrollment expected in the third quarter of 2020.
Blade Therapeutics appoints Mark Timney as board chairman, succeeding co-founder Luke Evnin; the release recalls its roughly $90 million raised from investors including OneVentures and The Medicines Company's $9.7 billion sale to Novartis.
OneVentures announces it has closed its first venture debt fund, described as the largest of its kind in Australia. No fund size, target or details are given on the page.
Under OneVentures portfolio ·leads this story in the feed
OneVentures announces that its credit fund has reached final close at $80 million, referring readers to the Australian Financial Review for further detail.
OneVentures announces ten million dollars of equity and credit financing for business intelligence firm Phocas, combining a recent credit facility with a 2018 equity investment, as the company prepares for international growth.
Also phocassoftware.com
OneVentures' blog reposts coverage of Phocas Software, a veteran data analytics firm that turned to venture backing, with the page also recording the investor's investment and a later $45 million raise.
Also OneVentures portfolio·OneVentures portfolio·SmartCompany
Pearson has bought Smart Sparrow's adaptive learning technology in a deal valuing the Sydney edtech firm's assets at US$25 million, to strengthen Pearson's digital learning platform and e-book offerings.
A brief OneVentures post pointing readers to Post & Parcel's coverage of Shippit's planned expansion across Australian and Asian markets; the piece itself states no deal, raise, or personnel details.
OneVentures announces on its blog that it has backed Shippit, a retail logistics business, referring readers to Australian Financial Review coverage for details.
A brief OneVentures blog post directing readers to Wall Street Journal coverage about needle-free flu vaccination, stating no company news, funding, or deal details of its own.
Safety-tech firm iStaySafe has bought Brisbane wearable maker Find-Me Technologies, and investors in both companies, including OneVentures, have secured matching investment from Queensland's Business Development Fund.
Brisbane immunology company Kira Biotech has launched with a $20 million Series A, OneVentures leading alongside IP Group and Queensland government support, to progress its lead antibody KB312 into early human studies.
Airbnb property management startup Hometime closed a $6 million venture debt and equity round via OneVentures' 1V Venture Credit Fund, the fund's first investment, ahead of a planned Series A in early 2020.
OneVentures appoints Jim Scopa and Dan Baker to its healthcare investment team, and recalls its Healthcare Fund III backing Blade Therapeutics and BiVACOR.
Deals recorded from OneVentures portfolio's coverage. A round is listed once, however many of their articles mention it.
| Company | Stage | Announced | Amount | Investors |
|---|---|---|---|---|
| Employment Hero | Unnamed stage | 19 Oct 2023 | $263m | |
| ImmVirX | undisclosed | Jun 2023 | $15m | |
| Vaxxas | Unnamed stage | 6 Dec 2022 | $34m | |
| Kepler Analytics | Series B | 23 Feb 2022 | $22m | |
| Flippa | Series A | 20 Sep 2021 | $11m | |
| Lumary | Unnamed stage | 30 Mar 2021 | $17m | |
| Employment Hero | Series D+ | 2 Mar 2021 | $45m | |
| Coassemble | Venture debt | 19 Feb 2021 | $1.5m | |
| InDebted | Venture debt | 9 Feb 2021 | $14m | |
| Phocas Software | Unnamed stage | 29 Jan 2021 | $45m | |
| Shippit | Unnamed stage | 1 Dec 2019 | $5.4m | |
| Phocas | Unnamed stage | Jun 2018 | $7m | |
| BiVACOR | Series A | May 2018 | $3m |
Companies named in OneVentures portfolio's articles, most-covered first.
Investors named in OneVentures portfolio's articles, most-covered first.
| Investor | What it does | Articles |
|---|---|---|
| OneVentures | 36 | |
| Biomedical Translation Fund | 3 | |
| Queensland Business Development Fund | 2 | |
| Salesforce | 2 | |
| IP Group Australia | Venture firm backing early-stage science and technology companies | 1 |
| Salesforce Ventures | 1 | |
| South Australian Venture Capital Fund | 1 |